IPO

Investment firm Birchtree Investments makes a bold leap into decentralized finance, acquiring Web3 innovator Digital Motion in a $20 million all-stock deal.

Pune-based EV maker reports massive growth and global expansion plans, navigating a fiercely competitive market while pioneering hydrogen fuel cell technology.

Expanded Medicare payment for RefleXion's SCINTIX therapy removes major financial hurdles, opening doors for advanced cancer care in community centers.

Amid global uncertainty, Centri’s exclusive NYC conference connects capital with 70+ high-growth firms in AI, fintech, and life sciences.

The tech firm posts impressive growth from defense and EV sectors, but a 'going concern' notice in its annual report reveals significant liquidity challenges.

With its pure-play chemical transition complete, Ascent adds two heavyweights to its board, signaling an aggressive new phase of growth and M&A.

A new partnership between Cartrack and Maharishi Institute aims to create a direct path from education to employment, offering a strategic model for a nation in need.

Meiwu Technology is executing a massive 1-for-100 reverse split to save its Nasdaq listing. Is this a savvy move for its skincare pivot or a desperate act?

U.S. Gold Corp.'s Wyoming project eyes new revenue from waste rock and water storage, promising a broader economic and infrastructure impact for the region.

ViewSonic launches a new subscription plan in Malaysia, shifting high-tech displays from a costly purchase to an affordable service for schools and businesses.

XPeng reports an 80% monthly sales jump but a yearly decline, while launching a major strategic expansion into Mexico and Latin America.

A new Swiss broker launches, blending active trading with savings and interest on idle cash. But questions around its regulatory status and platform claims remain.

Metals developer Serval Resources launches an AIM IPO and retail offer, banking on African copper projects to power the global green energy transition.

INLIF LIMITED's 1-for-16 reverse stock split aims to secure its Nasdaq listing, but is it a strategic fix or a sign of deeper financial trouble?

Onfolio Holdings reports 36% revenue growth and positive EBITDA, but a wider net loss and auditor warnings reveal a high-stakes strategy for 2026.

The biopharma firm touts transformative drug data ahead, but with cash for only month-to-month operations, its future hangs by a precarious thread.

The energy services firm reports a 90% jump in adjusted EBITDA, crediting disciplined spending and a lucrative foray into the Alaskan snubbing market.

With a seasoned team and $253 million in fresh capital, Inflection Point's new SPAC signals strong investor confidence in a disciplined market.

Securityholders overwhelmingly approve a C$0.90 per share cash offer from Mansa Resources, paving the way for the Dugbe Gold Project's private development.

With FDA approval, soaring revenues, and game-changing clinical data, InspireMD prepares to spotlight its CGuard Prime stent for investors this April.